홈
마켓
차트 & 아이디어
Algo
뉴스
Store
브로커
다운로드
경제 달력
트레이딩 시그널
웹터미널
Heatmap
검색
/
타입: @user, $symbol
검색
로그인
계정을 생성하십시오
한국어
English
Русский
中文
Español
Português
日本語
Deutsch
Français
Italiano
Türkçe
VRCA
#4015
Verrica Pharmaceuticals Inc. Common Stock
5.830
0
USD
+1.92%
부문:
헬스케어
베이스:
USD
수익 통화:
USD
일일 변동 비율
년간 변동
일일 변동
+1.92%
월간 변동
-4.27%
6달 변화
-3.16%
년간 변동율
-3.16%
이전 종가
5.720
0
Open
5.855
0
Bid
Ask
Low
5.830
0
High
5.910
0
양
12
마켓
주식
헬스케어
VRCA
Open full chart
Financials
Overview
성명
Statistics
Quarterly
Annual
Value
Q4, 24
Q1, 25
Q2, 25
Q3, 25
Q4, 25
TTM
Key stats
Total common shares outstanding
9.18 M
9.25 M
9.45 M
9.49 M
17.18 M
—
Valuation ratios
Enterprise value
49.8 M
39.93 M
60 M
42.09 M
113.19 M
255.21 M
Price to earnings ratio
-0.47
-0.39
-0.69
-1.52
-4.95
-7.55
Price to sales ratio
4.79
3.81
3.82
1.31
2.49
11.43
Price to cash flow ratio
-0.6
-0.45
-0.72
-0.96
-5.02
-7.16
Price to book ratio
-3.68
-0.32
-0.41
-0.57
3.58
2.28
EBITDA 비율에 대한 기업 가치
-0.74
-0.7
-1.5
-2.37
-9.28
-13.85
Profitability ratios
Return on assets %
-0.3
-0.23
0.01
-0.01
-0.17
-0.4
Return on equity %
1.64
0.52
-0.01
0.02
-0.33
0.2
Return on invested capital %
-149.28
—
—
—
-126.38
—
Gross margin %
-132.56
79.65
100
97.21
98.04
374.89
Operating margin %
-3 316.86
-236.41
11.89
11.34
-141.24
-354.42
EBITDA margin %
-3 504.65
-252.81
12.88
9.32
-140.98
-371.59
Net margin %
-4 709.88
-283.28
1.61
-1.91
-158.56
-442.15
Liquidity ratios
Quick ratio
1.68
1.26
1.17
1.18
2.45
6.06
Current ratio
1.76
1.34
1.26
1.25
2.59
6.44
Inventory turnover
—
—
—
0.17
0.04
—
Asset turnover
0.01
0.07
0.31
0.36
0.12
0.86
Solvency ratios
Debt to assets ratio
0.59
0.68
0.65
0.54
0.01
1.88
Debt to equity ratio
-3.23
-1.54
-1.45
-1.31
0.02
-4.27
Long term debt to total assets ratio
0.57
0.66
0.63
0.53
0
1.82
Long term debt to total equity ratio
-3.14
-1.5
-1.41
-1.27
0
-4.17
Per share metrics
Operating cash flow per share
-3.1
-1.34
-1.06
1.02
-0.43
-1.81
EBIT per share
-2.36
-0.93
0.16
0.13
-0.68
-1.33
EBITDA per share
-2.33
-0.92
0.17
0.14
-0.67
-1.28
Total debt per share
6.15
3.02
2.67
2.35
0.05
8.09
Cash per share
1.93
1.05
1.62
2.22
2.83
7.73
Net current asset value per share
9.88
4.16
3.88
3.82
3.99
15.85
Tangible book value per share
-1.9
-1.96
-1.84
-1.8
2.32
-3.27
Working capital per share
4.28
1.06
0.8
0.78
2.45
5.09
Book value per share
-1.9
-1.96
-1.84
-1.8
2.32
-3.27
뉴스
Verrica Pharmaceuticals Inc. (VRCA) Q4 2025 Earnings Call Transcript
베리카 파마슈티컬 주가, 파트너사의 일본 내 YCANTH 출시 후 상승
Verrica Pharmaceuticals stock rises after partner launches YCANTH in Japan
Verrica’s partner launches molluscum treatment in Japan
Verrica Pharmaceuticals (VRCA) Upgraded to Strong Buy: Here's Why
New Strong Buy Stocks for February 2nd
How Much Upside is Left in Verrica Pharmaceuticals (VRCA)? Wall Street Analysts Think 97.11%
베리카 파마슈티컬스, TD Cowen ’매수’ 등급 재확인에 상승세
Verrica Pharmaceuticals stock advances as TD Cowen reiterates Buy rating
Verrica doses first patient in phase 3 trial for common wart treatment
베리카 파마슈티컬스, 이사회에 Charles Frantzreb 임명 및 주식 부여 승인
Verrica Pharmaceuticals appoints Charles Frantzreb to board and approves equity grants